Literature DB >> 31028287

How to set up a Hydroxychloroquine Retinopathy Screening Service.

Farhan H Zaidi1,2,3, Christina A Rennie4,5, Amie K Drinkwater5, Debendra Sahu4,5, Engin Akyol5, Andrew J Lotery4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31028287      PMCID： PMC7002420          DOI： 10.1038/s41433-019-0418-y

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

1.  Joint recommendations for retinal screening in long-term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018.

Authors:  I H Yusuf; A J Lotery; M R Ardern-Jones
Journal:  Br J Dermatol       Date:  2018-09-05       Impact factor: 9.302

2.  Hydroxychloroquine retinopathy: an emerging problem.

Authors:  M Latasiewicz; H Gourier; I H Yusuf; R Luqmani; S M Sharma; S M Downes
Journal:  Eye (Lond)       Date:  2017-02-10       Impact factor: 3.775

3.  Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine.

Authors:  Imran H Yusuf; Joanna M Ledingham; Elizabeth MacPhie; Andrew J Lotery; James Galloway
Journal:  Rheumatology (Oxford)       Date:  2019-01-01       Impact factor: 7.580

4.  Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine.

Authors:  Andrew J Lotery; Imran H Yusuf
Journal:  Br J Gen Pract       Date:  2018-03       Impact factor: 5.386

5.  The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.

Authors:  Ronald B Melles; Michael F Marmor
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

6.  Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation.

Authors:  David R Lally; Jeffrey S Heier; Caroline Baumal; Andre J Witkin; Steven Maler; Chirag P Shah; Elias Reichel; Nadia K Waheed; Igor Bussel; Adam Rogers; Jay S Duker
Journal:  Int J Retina Vitreous       Date:  2016-07-18
  6 in total
  1 in total

Review 1.  Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity.

Authors:  Siya Kamat; Madhuree Kumari
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.